Expertise in

conditions

Alain Saraux

CHU De Brest

Brest, FR

Expertise in

conditions

CHU De Brest

Brest, FR

Overview

Alain Saraux practices practicing medicine in Brest, France.

Mr. Saraux is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Whipple Disease, Dry Mouth, Rhizomelic Pseudopolyarthritis, and Rheumatoid Arthritis (RA).

He is actively involved in clinical research, co-authoring 308 peer reviewed articles and participating in 9 clinical trials.

Gender

Male

Locations

CHU de Brest
Brest, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Randomized Placebo-controlled Trial Comparing Methotrexate vs. Methotrexate/Metformin Association in Rheumatoid Arthritis Patients

Enrollment Status: Completed

Publish Date: July 08, 2026

Intervention Type: Other, Drug

Study Drugs: Metformin, Methotrexate

Study Phase: Phase 2

Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes

Enrollment Status: Completed

Publish Date: May 19, 2026

Intervention Type: Drug

Study Drugs: NSAIDs, anti-TNF

Study Phase: Phase 3

A Follow-up Phase 2a Open-label Study to Evaluate the Long-term Safety and Efficacy Profile of ABX464 in Patients With Moderate to Severe Active Rheumatoid Arthritis

Enrollment Status: Completed

Publish Date: November 17, 2025

Intervention Type: Drug

Study Drug: ABX464

Study Phase: Phase 2

Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis

Enrollment Status: Completed

Publish Date: November 18, 2024

Intervention Type: Drug, Biological

Study Drugs: Secukinumab, TNF blocker, Blood specimen

Study Phase: Phase 4

Phase IIa Randomized, Double Blind, Placebo Controlled, Multiple Dose Study on ABX464 in Combination With Methotrexate (MTX), in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have Inadequate Response to MTX or/and to Anti-Tnfα, or Intolerance to Anti-Tnfα

Enrollment Status: Completed

Publish Date: February 15, 2023

Intervention Type: Drug

Study Drugs: ABX464, Methotrexate

Study Phase: Phase 2

Assessment of the Clinical and Medico-economic Impact of SinnoTest®, a Software That Predicts the Effectiveness of Biotherapy Treatments, in Patients With Rheumatoid Arthritis (RA)

Enrollment Status: Withdrawn

Publish Date: May 03, 2021

Intervention Type: Diagnostic test, Drug

Study Phase: Not Applicable

Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORE

Enrollment Status: Completed

Publish Date: December 04, 2020

Intervention Type: Drug

Study Phase: Phase 3

Lead Time of the Methotrexate Establishment and Vaccinal Protection Against the Pneumococcal Agent in Patients Affected With Rheumatoid Polyarthritis

Enrollment Status: Completed

Publish Date: August 03, 2020

Intervention Type: Biological, Drug

Study Phase: Phase 3

A National, Randomized, Open-label Study Comparing Compliance and Evolution of Functional Capacity of Patients With Rheumatoid Arthritis Treated With Methotrexate Administered by Auto-injector Versus Administration by Conventional Subcutaneous Injection.

Enrollment Status: Completed

Publish Date: October 06, 2017

Intervention Type: Drug

Study Phase: Phase 3

View 8 Less Clinical Trials

308 Total Publications

Erratum for: Ten-year Longitudinal Relationship between Spinal Degenerative Lesions in Axial Spondyloarthritis at MRI and Radiography in the DESIR Cohort.

Journal: Radiology

Published: July 28, 2026

View All 308 Publications

Frequently Asked Questions about Alain Saraux

Is Alain Saraux a top-rated expert for Whipple Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Alain Saraux is classified as an Elite expert for Whipple Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Alain Saraux participate in research or clinical trials?

Yes. Alain Saraux has published 308 articles and abstracts on conditions like Whipple Disease. You can view a list of Alain Saraux's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Saraux's expertise for a condition

ConditionClose